Aphios receives NIH’s Stage II SBIR grant to develop APH-0703 for AD Aphios Corporation offers received a Stage II SBIR grant from the National Institutes of Health amounting to $2.4 million over two years cialis pour femme . The National Institute on Ageing , part of the NIH, awarded the grant to the Aphios Company to develop an Alzheimer’s Disease Therapeutic. Alzheimer’s Disease is the third leading cause of death in America and among the best in the industrial world.
THE MOST WELL-LIKED Solutions Partner Program will allow medical and dental resellers to offer an industry-leading clearinghouse claims processing solution to their clients. We value our romantic relationship with our partners as we mutually make an effort to offer a total set of solutions to medical and dental care providers that allows them to get accurate payments quickly. Our partners need not worry about their clients’ claims, allowing them additional time to spotlight meeting other needs of their customers. As a Favored Solutions Partner, Apex partners get the chance to enhance their recurring income through a customizable rebate system.